Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised open two-way cross-over study of new salbutamol HFA 134a vs Ventolin Evohaler in adult asthma
2005-000276-40Phase 3Completed
- Sponsor
- Generics
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of salbutamol in asthma (2 arms), sponsored by Generics. Primary endpoints: Bronchodilating properties comparability and Safety and tolerability. Started Feb 2005; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-000276-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000276-40.